Table 1 Characteristics of patients with ARDS caused by SARS-CoV-2 or influenza A/B. For laboratory data, maximum values are shown. p value reported in bold if difference is significant (p < 0.05). Data are given as mean ± standard deviation or number of patients (percent of all patients in group). aStudent’s t test; bWelch t test, cchi-square test; dFisher’s exact test
From: Is delirium a specific complication of viral acute respiratory distress syndrome?
Influenza (N = 16) | COVID-19 (N = 20) | p | |
|---|---|---|---|
Age | 54.31 ± 12.36 | 65.48 ± 10.99 | 0.007a |
Female | 5 (31.3%) | 4 (20.0%) | 0.470d |
ICU stay (days) | 19.85 ± 12.09 | 21.05 ± 11.77 | 0.765a |
Death | 0 (0%) | 2 (10.0%) | 0.492d |
Severe ARDS | 11 (68.8%) | 9 (45.0%) | 0.154c |
Days of invasive ventilation | 18.28 ± 15.61 | 15.47 ± 10.34 | 0.522a |
TISS 10 | 16.63 ± 5.73 | 15.25 ± 6.77 | 0.521a |
SAPS 2 | 40.38 ± 9.88 | 44.70 ± 11.13 | 0.232 |
Noradrenalin > 1 mg/h | 8 (50.0%) | 10 (50%) | 1.000 |
Renal replacement therapy | 4 (25.0%) | 6 (30.0%) | 1.000 |
Lactat mmol/l | 3.35 ± 1.82 | 3.07 ± 2.23 | 0.369 |
CRP mg/dl | 302.99 ± 96.89 | 257.34 ± 84.46 | 0.140 |
Procalcitonin ng/ml | 59.22 ± 106.43 | 17.19 ± 33.46 | 0.159 |
Delirium | 12 (75.0%) | 13 (65.0%) | 0.718 |
Delirium duration (days) | 2.83 ± 2.44 | 5.08 ± 4.29 | 0.126 |
NuDesc score at maximum | 3.67 ± 1.78 | 5.15 ± 2.58 | 0.109 |
Delirium onset after extubation (days) | 0.80 ± 1.55 | 0.50 ± 1.08 | 0.622 |